InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Rhonda Farnum, a SVP, COMM & MEDICAL AFFAIRS, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 16 open-market SEC Form 4 transactions: 0 purchases worth $0 and 16 sales worth $1.2M, reported from Feb 28, 22 to Jun 15, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 26 | TBPHTheravance Biopharma, Inc. | SELL | 6.7K | $16.39 | $109K |
| Mar 16, 26 | TBPHTheravance Biopharma, Inc. | SELL | 15.5K | $14.00 | $217K |
| Dec 3, 25 | TBPHTheravance Biopharma, Inc. | SELL | 15.5K | $18.75 | $291K |
| Jul 14, 25 | TBPHTheravance Biopharma, Inc. | SELL | 5.3K | $11.39 | $61K |
| Jun 2, 25 | TBPHTheravance Biopharma, Inc. | SELL | 24.0K | $11.00 | $264K |
| Apr 21, 25 | TBPHTheravance Biopharma, Inc. | SELL | 4.0K | $9.00 | $36K |
| Jan 21, 25 | TBPHTheravance Biopharma, Inc. | SELL | 4.0K | $9.00 | $36K |
| Nov 11, 24 | TBPHTheravance Biopharma, Inc. | SELL | 4.0K | $9.00 | $36K |
| Jul 10, 24 | TBPHTheravance Biopharma, Inc. | SELL | 4.0K | $9.00 | $36K |
| Feb 22, 24 | TBPHTheravance Biopharma, Inc. | SELL | 1.3K | $8.71 | $11K |
| Nov 21, 23 | TBPHTheravance Biopharma, Inc. | SELL | 1.4K | $10.29 | $14K |
| Aug 22, 23 | TBPHTheravance Biopharma, Inc. | SELL | 1.8K | $9.47 | $17K |
| Jun 8, 23 | TBPHTheravance Biopharma, Inc. | SELL | 1.8K | $11.13 | $20K |
| Mar 9, 23 | TBPHTheravance Biopharma, Inc. | SELL | 4.0K | $10.20 | $41K |
| May 23, 22 | TBPHTheravance Biopharma, Inc. | SELL | 1.1K | $8.93 | $10K |
| Feb 28, 22 | TBPHTheravance Biopharma, Inc. | SELL | 2.4K | $10.16 | $24K |